Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-23-031704

Options or other derivatives

  • Director acquired 1,884 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Ferrante Karen Jean Director 2023-07-03 Grant or award · Stock Option (Right to Buy) +1,884 1,884 D
Loading xslF345X04/ownership.xml…